Severe atopic dermatitis (AD) produces painful, itchy and unsightly patches that disrupt sleep and have been linked to increased risk of depression. Now researchers have analyzed findings from a randomized follow-up trial in adults from two previous studies (SOLO 1 and SOLO 2) and found that maintenance monotherapy with dupilumab (Dupixent, Regeneron) at 300 mg...